Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

INTRODUCTION: Tocilizumab is used in patients with severe COVID-19 pneumonia and high concentration of IL-6. We studied potential prognostic role of neutrophil and lymphocyte count regarding tocilizumab treatment. MATERIALS AND METHODS: We enrolled 31 patients with severe COVID-19 pneumonia and high...

Descripción completa

Detalles Bibliográficos
Autores principales: Palčić Marija, Gomerčić, Hana, Matijaca, Ivan, Kruljac, Lucija, Vusić, Vedran, Hostić, Luka, Vrbanić, Mrsić, Fanika, Radovan, Zrilić, Ivana, Ćelap, Petar, Gaćina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Society of Medical Biochemistry and Laboratory Medicine 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231768/
https://www.ncbi.nlm.nih.gov/pubmed/37324114
http://dx.doi.org/10.11613/BM.2023.020704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231768/
https://www.ncbi.nlm.nih.gov/pubmed/37324114
http://dx.doi.org/10.11613/BM.2023.020704

Ejemplares similares